Literature DB >> 9162082

Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase.

K Reif1, B M Burgering, D A Cantrell.   

Abstract

Phosphatidylinositol 3-kinase (PI 3-kinase) is activated by the cytokine interleukin-2 (IL-2). We have used a constitutively active PI 3-kinase to identify IL-2-mediated signal transduction pathways directly regulated by PI 3-kinase in lymphoid cells. The serine/threonine protein kinase B (PKB)/Akt can act as a powerful oncogene in T cells, but its positioning in normal T cell responses has not been explored. Herein, we demonstrate that PKB is activated by IL-2 in a PI 3-kinase-dependent fashion. Importantly, PI 3-kinase signals are sufficient for PKB activation in IL-2-dependent T cells, and PKB is a target for PI 3-kinase signals in IL-2 activation pathways. The present study establishes also that PI 3-kinase signals or PKB signals are sufficient for activation of p70 S6 kinase in T cells. PI 3-kinase can contribute to, but is not sufficient for, activation of extracellular signal-regulated kinases (Erks) and Erk effector pathways. Therefore, PI 3-kinase is a selective regulator of serine/threonine kinase signal transduction pathways in T lymphocytes, and this enzyme provides a crucial link between the interleukin-2 receptor, the protooncogene PKB, and p70 S6 kinase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9162082     DOI: 10.1074/jbc.272.22.14426

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance.

Authors:  K Yamauchi-Takihara; T Kishimoto
Journal:  Int J Exp Pathol       Date:  2000-02       Impact factor: 1.925

2.  A human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling.

Authors:  M L Boytim; P Lilly; K Drouvalakis; S C Lyu; R Jung; A M Krensky; C Clayberger
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

3.  Akt-mediated survival of oligodendrocytes induced by neuregulins.

Authors:  A I Flores; B S Mallon; T Matsui; W Ogawa; A Rosenzweig; T Okamoto; W B Macklin
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

4.  Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells.

Authors:  Steven J Bensinger; Patrick T Walsh; Jidong Zhang; Martin Carroll; Ramon Parsons; Jeffrey C Rathmell; Craig B Thompson; Matthew A Burchill; Michael A Farrar; Laurence A Turka
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

5.  Signaling through CD5 activates a pathway involving phosphatidylinositol 3-kinase, Vav, and Rac1 in human mature T lymphocytes.

Authors:  S I Gringhuis; L F de Leij; P J Coffer; E Vellenga
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

Review 6.  FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis.

Authors:  Zainab Jagani; Amrik Singh; Roya Khosravi-Far
Journal:  Biochim Biophys Acta       Date:  2007-10-16

7.  Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B.

Authors:  Jose M Lizcano; Saif Alrubaie; Agnieszka Kieloch; Maria Deak; Sally J Leevers; Dario R Alessi
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

Review 8.  Recent advances in the understanding of interleukin-2 signal transduction.

Authors:  F Gesbert; M Delespine-Carmagnat; J Bertoglio
Journal:  J Clin Immunol       Date:  1998-09       Impact factor: 8.317

Review 9.  Regulatory T cells overturned: the effectors fight back.

Authors:  Lucy S K Walker
Journal:  Immunology       Date:  2009-04       Impact factor: 7.397

Review 10.  PIP3 pathway in regulatory T cells and autoimmunity.

Authors:  Masaki Kashiwada; Ping Lu; Paul B Rothman
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.